about
Effect of Dietary ω-3 Polyunsaturated Fatty Acid DHA on Glycolytic Enzymes and Warburg Phenotypes in CancerKlotho sensitizes human lung cancer cell line to cisplatin via PI3k/Akt pathwayActivation of Akt is increased in the dysplasia-carcinoma sequence in Barrett's oesophagus and contributes to increased proliferation and inhibition of apoptosis: a histopathological and functional studyThe necrotic signal induced by mycophenolic acid overcomes apoptosis-resistance in tumor cells.Caffeine and the analog CGS 15943 inhibit cancer cell growth by targeting the phosphoinositide 3-kinase/Akt pathway.Energy restriction as an antitumor target of thiazolidinediones.Posttranslational modification of 6-phosphofructo-1-kinase as an important feature of cancer metabolism.The ubiquitin-proteasome system as a molecular target in solid tumors: an update on bortezomib.Molecular imaging of metastatic potential.Temsirolimus in the treatment of relapsed or refractory mantle cell lymphoma.TOR and ageing: a complex pathway for a complex process.Cancer chemoprevention: scientific promise, clinical uncertainty.Glycolysis, tumor metabolism, cancer growth and dissemination. A new pH-based etiopathogenic perspective and therapeutic approach to an old cancer questionTRAIL sensitisation by arsenic trioxide is caspase-8 dependent and involves modulation of death receptor components and Akt.Early development of the Toll-like receptor 9 agonist, PF-3512676, for the treatment of patients with advanced cancers.Hexokinase II integrates energy metabolism and cellular protection: Akting on mitochondria and TORCing to autophagy.c-Myc dependent expression of pro-apoptotic Bim renders HER2-overexpressing breast cancer cells dependent on anti-apoptotic Mcl-1Detection of pAkt protein in imprint cytology of invasive breast cancer: Correlation with HER2/neu, hormone receptors, and other clinicopathological variables.eEF-2 kinase dictates cross-talk between autophagy and apoptosis induced by Akt Inhibition, thereby modulating cytotoxicity of novel Akt inhibitor MK-2206.Cytokine stimulation promotes glucose uptake via phosphatidylinositol-3 kinase/Akt regulation of Glut1 activity and trafficking.mTOR regulates cell survival after etoposide treatment in primary AML cellsSynergistic apoptosis of MCF-7 breast cancer cells by 2-methoxyestradiol and bis(ethyl)norspermineMetabolic consideration of epiphyseal growth: survival responses in a taxing environmentHeat-shock protein 90 inhibitors in antineoplastic therapy: is it all wrapped up?The phosphoinositide 3-kinase signalling pathway as a therapeutic target in squamous cell carcinoma of the head and neck.Development of beta-amyloid-induced neurodegeneration in Alzheimer's disease and novel neuroprotective strategies.Heat-shock protein 90 inhibitors in cancer therapy: 17AAG and beyond.Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia.Phosphorylation of inositol 1,4,5-trisphosphate receptors by protein kinase B/Akt inhibits Ca2+ release and apoptosisTranscriptome correlation analysis identifies two unique craniosynostosis subtypes associated with IRS1 activation.Assessment of stanniocalcin-1 as a prognostic marker in human esophageal squamous cell carcinoma.Using Pharmacokinetic Profiles and Digital Quantification of Stained Tissue Microarrays as a Medium-Throughput, Quantitative Method for Measuring the Kinetics of Early Signaling Changes Following Integrin-Linked Kinase Inhibition in an In Vivo ModelSirolimus as primary treatment of acute graft-versus-host disease following allogeneic hematopoietic cell transplantation.Ptena and ptenb genes play distinct roles in zebrafish embryogenesis.Repositioning HIV protease inhibitors as cancer therapeuticsActivation of apoptosis by 1-hydroxy-5,7-dimethoxy-2-naphthalene-carboxaldehyde, a novel compound from Aegle marmelos.The phosphoinositide 3-kinase pathway in human cancer: genetic alterations and therapeutic implications.Role of Bcl-2 in tumour cell survival and implications for pharmacotherapy.Targeted approach to metastatic colorectal cancer: what comes beyond epidermal growth factor receptor antibodies and bevacizumab?The effect of 3-bromopyruvate on human colorectal cancer cells is dependent on glucose concentration but not hexokinase II expression.
P2860
Q26784557-483A5460-D37C-4020-8738-3CF608B3CA65Q28486480-5F2E6B3F-089C-45FB-91A4-DBE5FF036549Q33287238-6CFA1728-DBDD-4BF1-9755-427569254EA6Q33442825-3F4FE10B-5527-43C5-A3AC-1505D59EAA68Q33631453-4B0D3337-6C63-4755-B633-D533F6EC848BQ33744668-61C407FB-2924-4BFF-B691-CAD8B6CEC299Q33900808-9590F56C-E3FC-4204-A6E1-4B031D52E7EDQ33916030-F2D0F876-786F-47D3-B3F5-9022B34E983CQ33917943-8CD123C3-D3F9-4FC8-A478-C6FB9C880962Q34129360-E4462344-C94E-404D-8201-567CDAF09AA9Q34402682-79B6AB38-9B7C-4DC1-BA91-AF27960DE1B1Q34456971-C9E28143-008D-46C8-8E29-CCE259353925Q34459681-257AA746-1394-4FC9-867A-80A6C5E6952DQ34564468-8AD9AE27-0E5D-46A2-9F53-9C67E8D4F8A9Q34619324-D737142D-D51E-4DB7-B7FD-72672C8E1DC6Q34924245-CA42B1A1-335D-4A84-8F6C-FFA5F60AD6B8Q35218681-F5697F23-D918-45A1-9035-300D26BDF182Q35245409-F0C619AF-B20A-46C8-93D8-CBE09C7B06DEQ35534450-DFD033B2-5E6E-40B3-978A-AB37BF526C1FQ35723690-8FF4596D-D159-4D65-8606-686838B9EDD9Q35848196-177FD3EB-7600-4C0D-8342-FAB0B32CA86AQ35856599-BEC5436A-0363-4D9F-8528-998D19BE6004Q35928543-53B76FE9-39E6-4BB4-934F-3F24D6BC5395Q36187025-DE6ECC97-08E0-450B-BB60-868FAE73033DQ36219713-98320C39-8574-4290-AE48-90F7BC1B7605Q36329164-0E15136F-C4B7-4988-A0F0-55F0611F8508Q36429460-1C87CE4F-7AFE-4196-A179-C166931B79FAQ36461618-BD1C7FD6-0497-4CAF-B0F2-B2691108EDD5Q36497282-85F6D145-416C-413E-A65B-67448326A308Q36530869-A9192D25-49F3-411C-83DB-A5648669F7B5Q36642821-084F3A3F-5644-463C-9E81-D219DF79C84EQ36720975-5E6B9871-A024-48D7-B499-06FC2B8E2B55Q36868082-2DFF8AB7-61E0-42CF-BB6F-6A4D02EBDC40Q37032400-974EA2CC-7ED5-4D3F-8AF2-40941D484F5EQ37192579-34AB0595-C63E-4D1F-9A21-FBCF9A5C9A04Q37216528-B4C360D8-F52C-4DFE-A361-9F487EDF262AQ37454384-32B4E2DE-9D10-4CDF-9B20-565A954F9A1AQ38059246-C6259F10-CE59-448D-BCEA-35EBFC0F419CQ38074430-33D96243-8FEB-4F33-A464-A47FBD266025Q38556814-78F4514F-EC8C-4F52-913E-644CF9C8B545
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Putting the rap on Akt.
@ast
Putting the rap on Akt.
@en
type
label
Putting the rap on Akt.
@ast
Putting the rap on Akt.
@en
prefLabel
Putting the rap on Akt.
@ast
Putting the rap on Akt.
@en
P356
P1476
Putting the rap on Akt.
@en
P2093
Craig B Thompson
James E Thompson
P304
P356
10.1200/JCO.2004.01.103
P407
P577
2004-10-01T00:00:00Z